Black Diamond Therapeutics, Inc.
BDTX
$2.85
$0.020.71%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 70.00M | 70.00M | 70.00M | 70.00M | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 70.00M | 70.00M | 70.00M | 70.00M | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 70.00M | 70.00M | 70.00M | 70.00M | -- |
| SG&A Expenses | 16.57M | 18.58M | 20.26M | 25.73M | 27.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.13M | 58.14M | 65.30M | 74.01M | 78.78M |
| Operating Income | 19.87M | 11.86M | 4.71M | -4.01M | -78.78M |
| Income Before Tax | 22.37M | 21.50M | 14.44M | 5.09M | -69.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 22.37 | 21.50 | 14.44 | 5.09 | -69.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.37M | 21.50M | 14.44M | 5.09M | -69.68M |
| EBIT | 19.87M | 11.86M | 4.71M | -4.01M | -78.78M |
| EBITDA | 20.20M | 12.20M | 5.05M | -3.66M | -78.44M |
| EPS Basic | 0.40 | 0.38 | 0.25 | 0.08 | -1.27 |
| Normalized Basic EPS | 0.32 | 0.23 | 0.15 | 0.04 | -0.81 |
| EPS Diluted | 0.38 | 0.36 | 0.23 | 0.06 | -1.28 |
| Normalized Diluted EPS | 0.31 | 0.21 | 0.14 | 0.03 | -0.81 |
| Average Basic Shares Outstanding | 227.49M | 227.00M | 226.58M | 224.93M | 220.08M |
| Average Diluted Shares Outstanding | 228.50M | 228.01M | 227.59M | 225.94M | 220.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |